- 濵å éœäžé ç¬ç«è¡æ¿æ³äººåœç«ç é¢æ©æ§è¥¿åŒçäžå€®ç é¢ åŒåžåšå ç§éšé·
COVID-19ãšãã®æ²»çè¬
1. æ¥æ¬ã§ã®ææã®ç¶æ³
æ¥æ¬ã§ã¯ã1æ15æ¥ã«æåã®åœå çäŸã®å ±åã確èªãããŸããããã®åŸã1æäžã«12äŸãå ±åãããããã«ãªããŸããããã®ãã¡ã®ïŒäŸã¯ãå šãŠæŠæŒ¢åžã«é¢é£ããçäŸã§ãããæ®ãã®ïŒäŸã¯ãåœå ã§ææãããã®ãšèããããŸããããã®é ã¯ããŸã åŒåžåšå ç§èšºçã§ã察岞ã®ç«äºã®ãããªæèŠã§æ·±å»ã«èããŠããªãã£ãèšæ¶ããããŸãã
2æ1æ¥ã«ã¯ãæ¬äŒŒçãµãŒãã€ã©ã³ã¹ãããæå®ææçã«å€æŽããå±åºã®åœ¢åŒãå€ããã2æ3æ¥ã«ã¯ããã€ã¢ã¢ã³ãã¯ã«ãŒãºå·ãæ¥æ¬ãžåž°æž¯ããŠããŸãããŸããæŠæŒ¢åžããã®åž°åœäŸ¿ãåž°ã£ãŠããã®ããã®ææã«ãªããŸããã¢ã¡ãªã«ã®ææè å¢ã¯ã3æäžæ¬ããäžæ¬ã«ãããŠã§ããããã€ã¢ã¢ã³ãã¯ã«ãŒãºè¹ã«ã€ããŠãå šäžçã§ã察å¿ã«æ¹å€ããããŸããã
2æ18æ¥ããã¯ã«ãŒãºè¹ã®äžè¹ããã·ã§ã³ãéå§ããŠããŸãããã®é ãããåœå ã§ã®ã¯ã©ã¹ã¿ãŒã®äºäŸçºçãæ£èŠãããããã«ãªããŸãããåœåã¯ãã¯ã©ã¹ã¿ãŒã§ãæææºããããã®ã倧åã§ãããŸãããããã®åŸã3æäžæ¬é ãããäžççãªæµè¡æ¡å€§ã«äŒŽã£ãŠã欧米ããã®èŒžå ¥çäŸã次第ã«å¢ããŠãããŸãããã®åŸïŒæã®åŸåããçäŸæ°ã次第ã«å¢å ãããªã³ã¯ã®ããããªãïŒæææºã®è¿œè·¡ãè¿œããªãïŒæ£è ãå€æ°ãéãå¢ããŠãããŠããŸããïŒæ7æ¥ã®æ°åã€ã³ãã«ãšã³ã¶ç¹æªæ³ã«åºã¥ãç·æ¥äºæ 宣èšãçºããããã«è³ã£ãŠããŸãã
5æ6æ¥ãŸã§ã®ç·æ¥äºæ 宣èšãçºåºããæ¥æ¬æ¿åºã¯ã5æ4æ¥ã«ãç·æ¥äºæ 宣èšã®å»¶é·ãïŒã¶æãšããäºå®ãšãªããæææ¡å€§ã®åæãé£ããå±é¢ã«ãªã£ãŠããããšãç©èªã£ãŠããŸãã
2. åœå ã§ã®çœ¹æ£å¹Žä»£æ¯èŒ
ãæ¥æ¬åœå ã®ææéœæ§äŸã®å€ãã¯ãïŒïŒæ³ä»£ããïŒïŒæ³ä»£ã§ãããŸããçäŸæ°ãåäžä»£ã»ãŒåäžãšãªã£ãŠããŸããäžæ¹ã§ãïŒïŒä»£ä»¥äžã®å ããå²åã¯çŽïŒå²ã§ããããã«æ¯ã¹ãåäŸã¯ïŒïŒä»£ä»¥äžã®å ããå²åã¯ïŒãïŒ%ãšæ¥µããŠå°ãªãå ±åãšãªã£ãŠããŸããåäžä»£ãç·æ§ã女æ§ãããå€ããç·æ§ã6å²ãå ããŠããŸãã
3. å¢æªãªã¹ã¯ã«ã€ããŠ
ããŸã ãçäŸæ°ãå°ãªãäžã§ã®è§£æã®ãããä»åŸå€ããå¯èœæ§ããããŸãããçŸåšã以äžã®ãªã¹ã¯å åãææãããŠããŸãã
ãããéçåã®ãªã¹ã¯ãã¡ã¯ã¿ãŒã
ãã ïŒïŒæ³ä»¥äž
ããããç·æ§
æ ¢æ§ç掻ç¿æ £ç ïŒç³å°¿ç ãé«è¡å§ãé«èè¡çïŒ
ããã人工åŒåžåšç®¡çãšãªããªã¹ã¯ãã¡ã¯ã¿ãŒã
ãããããã
ããããå¿è¡ç®¡çŸæ£
4. æ²»çè¬ã«ã€ããŠ
A) ããããã«ã»ãªãããã«ïŒã«ã¬ãã©Â®ïžïŒ
ããããã«ã»ãªãããã«(LPV/r)ã¯ãã«ã¬ãã©ãšããŠAIDSã®æ²»çè¬ãšããŠäœ¿ãããŠããè¬ã§ããSARSè延ã®éãå°ãå¹æãããã®ã§ã¯ãªãããšèšããããšãããããä»åãå¹æãæåŸ ãããŠããŸãããäžåœã«ãããŠã100人ãš99人ãšãã«ã¬ãã©ã䜿çšãã矀ãšäœ¿çšããªãïŒçŸ€æ¯èŒè©Šéšãå®æœããNEJMã«å ±åãããŸãããèšåºçæ¹åãåŸããããŸã§ã®æéã«å·®ããªãããŠã€ã«ã¹ã®æå¶å¹æã«ãå·®ããªããšããŠããã®è«æã§ã¯æå¹æ§ãåŠå®ãããŠããŸãããã®ä»ãããã€ãè«æãåºãããŠããŸãããæ¯èŒçå¯äœçšãåºããããšã®ããšã§ãçŸåšæ¥æ¬ã§ã¯ç©æ¥µçã«äœ¿çšã¯ãããªããããªäœçœ®ä»ããšãªã£ãŠããŸãã
B) ãã¡ããã©ãã«ïŒã¢ãã¬ã³Â®ïžïŒ
ãã¡ããã©ãã«ã¯ãæ¥æ¬ã®å¯å£«ãã£ã«ã å¯å±±ååŠãéçºãããè¬ã§ããæ®å¿µãªããåç©å®éšã«ãŠå¬å¥åœ¢æãåŠå©Šã§èšŒæãããŠããããšãããçŸåšã§ã¯æã€ã³ãã«ãšã³ã¶æ²»çãšããŠããè¬äŸ¡ããã€ããŠããªãè¬å€ã§ãããä»åã®COVID-19ã«å¹ãã®ã§ã¯ãªãããšããŠãæ€èšãããæ¢ã«äžåœããå ±åãããŠããŸãããã¡ããã©ãã«ã䜿ã£ã35人ãšãã«ã¬ãã©çŸ€45åãã³ã³ãããŒã«ã«ããè©Šéšã§ãããã¡ããã©ãã«ïŒã¢ãã¬ã³ïŒçŸ€ãCTç»åã®æ¹åçããããã¯ãå¯äœçšã®åºçŸçãããããšã£ãŠãã³ã³ãããŒã«ããåªå¢ã§ãã£ããšããå ±åã§ãããŸãã
çºçåŸ7æ¥ä»¥å ã®æ¯èŒçæ©æããã€ãSpO2 93%以äžãªã©ãééçã®çäŸã察象ãšããŠããŸãã80äŸã®æ£è ããšã³ããªãŒããããã¡ããã©ãã«ïŒã¢ãã¬ã³ïŒçŸ€ã«35åïŒæäžéã¯åæ¥3200mg, 2æ¥ç®ä»¥é1200mgïŒãã«ã¬ãã©çŸ€ã«45åãå²ãä»ããããŸããããŠã€ã«ã¹æ¶å€±ãCTäžã®æ¹åãäž»èŠè©äŸ¡é ç®ã§ã¯ãday 14æç¹ã§äž¡è ãšãã«ãã¡ããã©ãã«ïŒã¢ãã¬ã³ïŒçŸ€ã§çµ±èšåŠçã«ææãªå·®ã§æ¹åãèªããŠããŸããæ害äºè±¡ã«ã€ããŠã¯ã«ã¬ãã©çŸ€ã®æ¹ãå€ãã£ããšãããŠããŸããæ¬è«æã¯biasãç¡èŠã§ããªããšããçç±ã«äžæåãäžããããŠããŸããããçŸåšã¯ãOpen access ãšããŠèŠãããšãã§ããŸãã(https://doi.org/10.1016/j.eng.2020.03.007)
ããŸãæ å ±
ã¢ãã¬ã³ã¯ãå¯å£«ãã£ã«ã å¯å±±ååŠãç¬å çã«è£œé ã»è²©å£²ã§ããããšæãããŸããããæ¢ã«ç¹èš±ãåããŠããã®ã§äžåœã®æ¹ã§ããããäœããããã«ãªããåææãäžåœã§äœã£ãŠããããã§ãã
C) ãªã«ãã¹ã³ïŒã·ã¯ã¬ãœããïŒ
ã·ã¯ã¬ãœããïŒãªã«ãã¹ã³ïŒã¯ãæ°ç®¡æ¯åæ¯ã®åžå ¥ã¹ããã€ãè¬ãšããŠç¥ãããŠããè¬ã§ããããã¯æç¥å»å€§ã®æ£®å³¶å çã®ç 究çã§ç 究ãããŠãããŸãããåœç«ææçç 究æã®æŸå±±å çããæ§ã ãªååŠã©ã€ãã©ãªãŒã®äžãããæåã¯MARSã³ãããŠã€ã«ã¹ã察象ãšããŠãå¹æã®ããããããæ¢çŽ¢ããŠããäžã§ãã·ã¯ã¬ãœãããšããè¬ãããŠã€ã«ã¹å¢æ®å¶åŸ¡ã®å¯èœæ§ãææããŸãããä»åã®COVIDãŒ19ã§ãå¹æãããã®ã§ã¯ãªãããšãå®èšåºã«ãŠããã®ãªã«ãã¹ã³ã䜿ãã3人ã«äœ¿ã£ãŠæå¹ã§ãã£ããšææçåŠäŒãžå ±åïŒç¥å¥å·çã®å²©æžå çãïŒãããŸãããçŸåšèšåºãåœç«åœéå»çç 究ã»ã³ã¿ãŒPIã§ã®ã軜çè ãžã®ïŒçŸ€æ¯èŒèšåºè©Šéšãè¡ãããŠããŸãã
D) ããã¡ã¢ã¹ã¿ããïŒããµã³Â®ïžïŒ
ããã¡ã¢ã¹ã¿ããïŒããµã³ïŒã§ãæ¥æ§èµççã«äœ¿ãããè¬å€ã§ãããã»ãªã³ãããã¢ãŒãŒé»å®³å€ã§ãããããã¡ã¢ã¹ã¿ãããMARSã³ãããŠã€ã«ã¹ã®ææã®æç«ãé®æãããšããå ±åã2016幎ã«å ±åãããŠããŸãïŒæ±äº¬å€§åŠã®ã°ã«ãŒãïŒãåã°ã«ãŒãããSARS-Cov-2ïŒCOVIDãŒ19)ã®ææãé»å®³ããåãããã®ã§ã¯ãªãããšå ±åããçŸåšæ³šç®ããããŠããŸããåœé¢ã§ãéçåããŠããCOVID-19æ£è ãžäœ¿çšã«ãŠåçã«æ¹åããçµéšãããŠããŸãïŒã¢ãã¬ã³ã®å°å ¥åã®ãããããµã³ãã䜿çšã§ããªãç¶æ³äžã§ã®çäŸïŒã
E) ã¬ã ãã·ãã«
ãããããããšãã©åºè¡ç±ãŠã€ã«ã¹çšã®å€ã§ãç±³åœã®ãªã¢ã瀟ãéçºãé²ããŠããŸãã4æ28æ¥ã®ãç¹äŸæ¿èªãå¶åºŠã䜿çšããæ¥æ¬åœå ã§ãæ©æã®äœ¿çšãæ€èšãããŠãããéçã®COVID-19æææ£è ã«å¯ŸããŠã®é©å¿ãšãããŠããããäžåœã§ã®èšåºè©Šéšã§ã¯å¹æããªãã£ããšå ±åãããŠãããŠããŸã ãäžæ確ãªéšåãå€ããããããéçåããæ£è ãžã®é©åãªè¬å€ãªç¡ãããšãããéå®çã«äœ¿çšãããããã«ãªããšæãããã
5. 西åŒçäžå€®ç é¢ãåŒåžåšå ç§ã®åãçµã¿
æ¥æ¬ã§ã¯ãæææ¡å€§ãç·©åŸã«é²ãã§ããŸããéåžžäºæ 宣èšãçºåºããèªç±ãªè¡åãå¶éãããŸããããææè æ°ã®æ¥æ¿ãªå¢å ã¯æããããäžå®ã®ææãèªããŠã¯ããŸããæææ£è ã¯ãæå®ææçã®ãããåºæ¬ã¯å ¥é¢æœèšã§ã®éé¢èŠ³å¯ãååãšãªããŸããããããçŸå®çã«ã¯ãå ¥é¢æœèšæ°ãå°ãªãããšããå°åã«ãã£ãŠã¯ããã«æœèšãå°ãªãèªå® åŸ æ©æ£è ãå€ãååšããŠããŸããåŒççã§ã¯ãèªå® åŸ æ©æ£è ã2åæ»äº¡ããå ±åããããŸããããããŠãæã ã®è¥¿åŒçäžå€®ç é¢ã§ããæ£è ãåããªãã£ããšãæ»äº¡ããå ±éãŸã§ãããŸããïŒæ±äº¬æ°èã®å ±éã®å 容ãšãäºå®ã¯ç°ãªãããšããããå ±éæ©é¢ãžã®çç³ãè¡ãªã£ãŠããŸããåŒåžåšå ç§ããåããŠå ±éã§æ¬æ¡ä»¶ãç¥ãé©ããŸãããïŒhttps://www.tokyo-np.co.jp/article/national/list/202005/CK2020050102000132.html
西åŒçäžå€®ç é¢åŒåžåšå ç§ãšããŠãäžççæææ£è ã®èšåºã»æ²»çãè¡ãªãåããå°åã§ã®èªå® åŸ æ©æ£è ãžã®æ¯æŽæŽ»åãéå§ããŸãããäŒæ¥ãææ²¢å»åž«äŒã®æ¯æŽãåããèªå® åŸ æ©æ£è ãžã®ãã«ã¹ãªãã·ã¡ãŒã¿âïŒïŒïŒåæã«ãããå»çç³»S N SãçšããŠã®ãæ£è ãµããŒããéå§ããŠããŸããèªå® åŸ æ©æ£è ã®å€ããäžå®ãæ±ããæ¥æ¿ã«å¢æªããå¯èœæ§ã®ãããã®ææçããã©ããŒããŠãããã®ãšãªããŸãã
COVID-19 Saitama Save Home Project
ãããããhttps://www.covid19-saitama-seibu-home-project.com
å šäžçã«åºããããã®ææçãå°ãã§ãæ©ãåæã§ããããšãé¡ã£ãŠããŸããäžçäžã©ãã§ããçãäžå®ãæ±ããŠããäžã®äžã«å€åããŠããŸããŸããããå¿ ãæããæªæ¥ããããšä¿¡ããŠãæ¥ã ãéãããŠåããŸããäžçãžåœ±é¿ããåãçµã¿ã§ã¯ãããŸããããææ²¢ãšããå°ããªå°åã§ã®æŽ»åãããäžæ©ãã€é²ãã§ããããšã倧åãšèããŠåãçµãã§ããŸããæããæªæ¥ãžåããŠïŒïŒ